Catalyst Wire Dossier Catalyst Wire Dossier

DBI-102

· DermBiont, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DBI-102, covering 2023-10-25 to 2023-10-25. Get the full timeline:

Most recent: Clinical Trial Update: Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos [Phase 2]

See pricing